Skopos Labs, Inc. Harmony Biosciences Holdings, Inc. Transaction History
Skopos Labs, Inc.
- $497 Million
- Q2 2025
A detailed history of Skopos Labs, Inc. transactions in Harmony Biosciences Holdings, Inc. stock. As of the latest transaction made, Skopos Labs, Inc. holds 1,064 shares of HRMY stock, worth $37,740. This represents 0.01% of its overall portfolio holdings.
Number of Shares
1,064
Previous 1,064
-0.0%
Holding current value
$37,740
Previous $35,000
5.71%
% of portfolio
0.01%
Previous 0.01%
Shares
2 transactions
Others Institutions Holding HRMY
# of Institutions
289Shares Held
47.9MCall Options Held
130KPut Options Held
46.5K-
Valor Management LLC Chicago, IL6.62MShares$235 Million91.68% of portfolio
-
Black Rock Inc. New York, NY5.84MShares$207 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.11MShares$181 Million0.0% of portfolio
-
Dimensional Fund Advisors LP Austin, TX1.58MShares$56.1 Million0.01% of portfolio
-
State Street Corp Boston, MA1.58MShares$56 Million0.0% of portfolio
About Harmony Biosciences Holdings, Inc.
- Ticker HRMY
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 59,161,400
- Market Cap $2.1B
- Description
- Harmony Biosciences Holdings, Inc., a commercial-stage pharmaceutical company, develops and commercializes therapies for patients with rare neurological disorders in the United States. Its product, WAKIX is a medication for the treatment of excessive daytime sleepiness in adult patients with narcolepsy. The company was formerly known as Harmony ...